trending Market Intelligence /marketintelligence/en/news-insights/trending/CxTDNe77GAOcCFff0eJLfw2 content esgSubNav
In This List

Kitov Pharma prices $6M registered direct offering of American depositary shares

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Kitov Pharma prices $6M registered direct offering of American depositary shares

Kitov Pharma Ltd. priced a registered direct offering of 3,428,572 American depositary shares at $1.75 apiece.

The Israeli drug developer expects to raise $6 million in gross proceeds from the offering.

Kitov Pharma will also issue unregistered warrants to purchase up to 2,571,430 ADSs. Each warrant can be exercised at $2 per ADS for a period of five and a half years.

H.C. Wainwright & Co. is the exclusive placement agent for the offering.

Tel Aviv, Israel-based Kitov Pharma expects to close the offering on or about Jan. 18 subject to closing conditions.